Not Rated
Fund Size
(1.22% of Investment in Category)
|
Expense Ratio
(0.88% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 05-Sep-25 | 10160.10 | 1.60% | - | 1.41% | 83/226 |
1 Month | 12-Aug-25 | 10279.30 | 2.79% | - | 3.32% | 121/224 |
3 Month | 12-Jun-25 | 10320.50 | 3.20% | - | 2.85% | 86/216 |
6 Month | 12-Mar-25 | 11702.30 | 17.02% | - | 16.94% | 93/211 |
YTD | 01-Jan-25 | 10141.30 | 1.41% | - | 3.47% | 119/201 |
1 Year | 12-Sep-24 | 10428.70 | 4.29% | 4.29% | -0.64% | 40/178 |
2 Year | 12-Sep-23 | 17199.50 | 72.00% | 31.10% | 20.08% | 5/139 |
3 Year | 12-Sep-22 | 21721.20 | 117.21% | 29.48% | 19.51% | 4/114 |
5 Year | 11-Sep-20 | 28052.50 | 180.53% | 22.88% | 23.86% | 47/90 |
Since Inception | 13-Jul-18 | 43790.00 | 337.90% | 22.86% | 14.08% | 24/199 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 12-Sep-24 | 12000 | 12898.71 | 7.49 % | 14.13 % |
2 Year | 12-Sep-23 | 24000 | 30120.5 | 25.5 % | 23.47 % |
3 Year | 12-Sep-22 | 36000 | 55264.9 | 53.51 % | 29.85 % |
5 Year | 11-Sep-20 | 60000 | 109093.51 | 81.82 % | 24.12 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 7212.8 | 11.71% | 0.02% | 15.45% (Sep 2024) | 11.69% (Jul 2025) | 45.24 L | 3.43 L |
Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 5838.1 | 9.47% | 0.62% | 9.66% (May 2025) | 8.28% (Jan 2025) | 46.33 L | 3.80 L |
Divis Laboratories Ltd. | Pharmaceuticals | 5689.6 | 9.23% | 1.10% | 9.23% (Aug 2025) | 1.86% (Nov 2024) | 9.28 L | 1.75 L |
Cipla Ltd. | Pharmaceuticals | 4556.2 | 7.39% | -0.15% | 9.71% (Jan 2025) | 6.52% (Sep 2024) | 28.67 L | -0.95 L |
Aurobindo Pharma Ltd. | Pharmaceuticals | 4021.9 | 6.53% | 0.82% | 7.05% (Apr 2025) | 4.26% (Sep 2024) | 39.13 L | 8.56 L |
Lupin Ltd. | Pharmaceuticals | 3353.3 | 5.44% | 0.33% | 5.44% (Aug 2025) | 3.79% (Jun 2025) | 17.70 L | 1.52 L |
Alkem Laboratories Ltd. | Pharmaceuticals | 2467 | 4.00% | 0.17% | 4.49% (Feb 2025) | 1.63% (Oct 2024) | 4.65 L | 0.00 |
Mankind Pharma Ltd. | Pharmaceuticals | 2157.6 | 3.50% | -0.37% | 4.2% (Jun 2025) | 0.62% (Nov 2024) | 8.73 L | -0.49 L |
Biocon Ltd. | Pharmaceuticals | 1978.7 | 3.21% | -0.43% | 5.02% (Jun 2025) | 0% (Sep 2024) | 56.80 L | 0.00 |
Gland Pharma Ltd. | Pharmaceuticals | 1772.8 | 2.88% | -0.33% | 4.63% (Sep 2024) | 2.88% (Aug 2025) | 9.47 L | 0.00 |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 3.63% |
Net Receivables | Net Receivables | 0.36% |
Margin | Margin | 0.14% |
Ratios calculated on daily returns for last 3 years (Updated as on 29th August, 2025)
Out of 108 mutual fund schemes offered by this AMC, 4 is/are ranked 5 * , 6 is/are ranked 4 * , 13 is/are ranked 3 * , 4 is/are ranked 2 * , 4 is/are ranked 1 * , and 77 schemes are not ranked. See more about AMC